1.Analysis of the risk factors of depression and life quality in patients with the first stroke
Chinese Journal of Primary Medicine and Pharmacy 2014;21(11):1688-1689
Objective To explore the risk factors of the stroke patients with depression and the life quality.Methods 300 patients with the first stroke were divided into depression group and non depression group.The risk factors of depression and the life quality were analyzed.Results The HAMD score of ≥ 45 years old patients was (21.28 ± 6.01),which was higher than that of < 45 years old (16.09 ± 4.15) (t =3.64,P =0.02).Medical burden from light to heavy were(12.53 ± 2.96),(16.11 ± 3.42) and (24.39 ± 6.11) (t =4.02,P =0.01).HAMD score without comorbid had significant difference(P =0.01).Logistic regression analysis showed that the influence factors of depression were associated with age,medical expenditure,complications and the degree of nervous function defect and others(OR =1.26,1.19,1.24,1.12,P =0.02,0.01,0.01).BI,FM and AS of the depression group were (57.19 ±6.27),(59.28 ±5.92) and(21.52 ±4.63),compared with the non depression group,the difference was significant(t =4.87,5.46,3.29,P =0.01,0.01,0.02).Conclusion The influence factors of depression were age,medical expenditure,complications and neurological deficits.The life quality of depression group was significantly lower than the non depression group.
2.Insulin-like growth factor 1 promotes in vitro proliferation of chondrocytes in traumatic arthritis
Guang ZHAO ; Jifeng JING ; Zhiyu ZHANG ; Jiajun ZHU ; Yan CUI
Chinese Journal of Tissue Engineering Research 2014;(2):183-186
BACKGROUND:The early damaged chondrocytes are susceptible to de-differentiate and exert unstable phenotype during the in vitro culture, thus needing some growth factors.
OBJECTIVE:To observe the promotion effect of insulin-like growth factor 1 on the in vitro proliferation of chondrocytes in adult rabbits with traumatic arthritis.
METHODS:Traumatic arthritis models of adult rabbits were established by using the modified Hulth method. After the models were successful y established, the distal femur and proximal tibia were harvested under sterile conditions, the chondrocytes were cultured. The cultured cells were divided into two groups:control group was cultured with Dulbecco’s modified Eagle’s medium containing 10%fetal bovine serum, while experimental group was cultured with Dulbecco's modified Eagle’s medium containing 100μg/L insulin-like growth factor 1. The effect of insulin-like growth factor 1 on the proliferation of chondrocytes in adult rabbits with traumatic arthritis was determined through the cytomorphology, cellcounting, and cellactivity.
RESULTS AND CONCLUSION:The chondrocytes in adult rabbits with traumatic arthritis were successful y cultured, the majority of cells were mini-cells, presenting smal fusiform, round or polygonal shape. Hematoxylin-eosin staining showed that the number of cells in experimental group was higher than that in control group. MTT assay found that the absorbance of cells in experimental group was greater than that in control group (P<0.01). Our findings indicate that, insulin-like growth factor 1 can promote the in vitro proliferation of chondrocytes in adult rabbits with traumatic arthritis.
3.Features of full field electroretinogram responses in children with early type 1 diabetes
Xueqing BAI ; Jifeng YU ; Wei SHI ; Yanhui CUI ; Wen LIU ; Lirong TIAN ; Li LI
Chinese Journal of Ocular Fundus Diseases 2016;32(3):287-290
Objective To observe the features of the full field electroretinogram (FF-ERG) in type 1 diabetes (T1D) children without diabetic retinopathy (DR).Methods Retrospective case study.Forty-one T1D children and 25 age-matched normal controls underwent a complete ophthalmic examination,including best-corrected visual acuity,refraction,intraocular pressure,slit lamp,fundus photography,indirect ophthalmoscopy,and spectral domain optical coherence tomography to exclude DR.All FF-ERG tests were performed by an experienced technician.The ERG series includes six protocols:dark-adapted 0.01 ERG (r-b 0.01);dark-adapted 3 ERG (mix-a 3.0,mix-b 3.0);dark-adapted 10 ERG (mix-a 10.0,mix-b 10.0);dark-adapted oscillatory potentials (OPS);light-adapted 3 ERG (c-a 3.0,c-b 3.0);light-adapted 30 Hz flicker (30 Hz FP) ERG.To compare the amplitudes and implicit times of the FF-ERG between the T1D and control group children.Results Compared with the control subjects,the FF-ERG amplitudes decreased and the implicit times increased in T1D.Except for r-b 0.01 (t =-0.228,P>0.05),the amplitudes of other FF-ERGs were all significantly attenuated (t =-1.664,-3.645,-4.324,-6.123,-5.846,-12.9,-14.4,-5.23;P<0.05) in T1D children.The implicit times of mix-b 3.0,mix-b 10.0,c-b 3.0 and OP2 significantly increased (t=5.242,2.879,5.378,3.506;P<0.05).The implicit times of r-b 0.01,mix-a 3.0,mix-a 10.0,c-a 3.0 and 30Hz FP changes were not significantly (t=2.331,1.677,0.557,0.84,0.064;P > 0.05).Conclusion The FF-ERG amplitudes decreased and implicit times increased in T1D children compared with the control normal subjects.
4.Correlation analysis of eye and neurological manifestations in 56 children with infantile gangliosideosis in China
Chunxia PENG ; Jifeng YU ; Xiaotun REN ; Lili LIU ; Yanhui CUI ; Wei SHI ; Li LI
Chinese Journal of Ocular Fundus Diseases 2021;37(5):352-358
Objective:To observe and analyze the clinical characteristics and correlation between the eye and nervous system in children with infantile gangliosideosis.Methods:From November 2018 to January 2021, 3 children with infantile ganglion lipidosis diagnosed by genetic examination in the Department of Ophthalmology and Neurology, Beijing Children's Hospital of Capital Medical University, and through China National Knowledge Infrastructure and Wanfang database and The National Library of Medicine of the United States (PubMed) were searched, and 53 cases of Chinese infantile gangliosideosis diagnosed by gene, enzyme activity or pathological examination were selected and a total of 56 cases were included in the study. The searching time was from the establishment of the database to February 2021, and the search keywords are"gangliosideosis", "cherry-spot" macula and "Chinese". The demographic characteristics of 56 cases of children and other system manifestations were analyzed such as eyes, nervous system, skin, bones. According to the presence or absence of cherry-spot (CS) on the fundus examination, the children were divided into a fundus CS group (group A) and a fundus without CS group (group B), with 20 and 27 cases, respectively. The age of onset, gender, different types and neurological manifestations of the two groups of children were compared and analyzed. The non-parametric rank sum test was used for age comparison between groups; the χ2 test or Fisher's exact test were used for the comparison of gender, disease type and incidence between groups. Results:Among the 56 children, 27 were males and 29 were females; the median age of onset was 7.0 months. There were 33 and 23 cases of GM1 and GM2, respectively. Among 44 children with visual function examination records, 41 cases (93.2%, 41/44) were unable to follow the visual object. Of 47 children who underwent ocular fundus examination, 20 cases (42.6%, 20/47) had CS on the fundus. The main manifestations of the nervous system are neuromotor development regression or retardation (100%, 56/56), convulsions (58.1%, 25/43), and "startle" phenomena (89.7%, 26/29). Among 42 patients with brain magnetic resonance imaging examination records, 39 cases (92.9%) were abnormal. The incidence of "startle" and seizures in group A was higher than that in group B, and the difference was statistically significant ( χ2=5.815, 6.182, P=0.021, 0.013). Conclusios:Chinese infantile gangliosideosis is more common in GM1 type. Ocular visual impairment is the visual object as the main manifestation, the incidence of fundus CS is 42.6%, and the symptoms of neurological damage in children with CS are more severe.
5.Research on the Clinical Usage of Orthosis
Yingyuan HU ; Huisan ZHAO ; Qihe CUI ; Jifeng ZHAO ; Ming YANG ; Yanchun LI ; Weihong WU ; Huabao LU
Chinese Journal of Rehabilitation Theory and Practice 1999;5(2):66-68
This research focused on the rehabilitation effect of orthosis for cerebral palsy(CP) children.46 CP children with physical dysfunction used the orthosis as an auxiliary therapy.The gait analysis,equilibrium,and comprehensive ADL measurement had been administrated pretherapy and post-therapy.The results show that 94.25% of CP children had improved their functions.The conclusions of this study indicated that it is important to use orthosis as an auxiliary therapy for CP children.Some important items of therapy had been discussed and the experiences of making plastic AFO had been introduced.
6.Effect of soluble worm antigen and soluble egg antigen of Schistosoma japonicum on apoptosis and cell-cycle of CD4~+ T lymphocytes
Cui ZHANG ; Xiaojun CHEN ; Jifeng ZHU ; Ying CHI ; Xiaoyun WEN ; Lei HE ; Sha ZHOU ; Feng LIU ; Chuan SU
Chinese Journal of Schistosomiasis Control 2010;22(1):13-16
Objective To investigate and compare the different effects of soluble adult wornl antigen(SWA)and soluble egg antigen(SEA)of Schistosoma japonicum on the apoptosis and cell-cycle of routine CD4~+T cells.Methods Purified CD4~+T ceUs from normal C57BL/6 mice were cultured with CFSE labeled antigen presenting clls in the presence of different stimuli for 36 h.Flow cytometry(FCM)was used to detect the apoptosis of CD4~+T cells by fluorescence conjugated caspase-3 antibodie staining.The flow cytometry was used to analyze the cell-cycle of CD4~+T cells cultured as described above for 96 h by propidium iodide staining.Results Compared with the apoptosis percentage of CD4~+T cells[(1.24±0.29)%]in the SEA stimulated group,that in the SWA stimulated group[(1.52±0.38)%]did not show statistically significant difference(P>0.05).Compared with the cell percentages in G1 phase[(78.91±2.98)%],S phase[(7.39±0.85)%]and G2/M phase[(10.69±1.05)%] in the SWA stimulated group,that of the G1 phase[(59.42±1.32)%]was significantly lower,but those in the S phase[(21.07±O.88)%] and G2/M phase[(18.88±1.21)%]were significantly increased in the SEA stimulated group(P<0.01).Conclusions There is no statistically significant difference between the apoptosis levels of CD4~+T ceHs stimulated by SWA and SEA.However,SEA significantly promotes the progression of the cell-cycle of CD4~+T cells compared with SWA.
7.Study on phytoestrogenic-like effects of four kinds of Chinese medicine including Radix Rehmanniae Preparata, Radix Paeoniae Alba, Radix Angelicae Sinensis, Rhizoma Chuanxiong.
Qingxiu HAO ; Jifeng WANG ; Jianzhao NIU ; Piwen ZHAO ; Ye CUI ; Liping SUN ; Xiaoou XUE
China Journal of Chinese Materia Medica 2009;34(5):620-624
OBJECTIVETo explore the phytoestrogenic-like effects of four kinds of Chinese medicine including Radix rehmanniae preparata, Radix Paeoniae Alba, Radix Angelicae Sinensis, Rhizoma Chuanxiong.
METHODSixty immature female SD rats weighting (70 +/- 5) g were randomly divided into six groups: normal control group, positive control group and 4 Chinese medicine groups. The rats in different groups were treated for 4 days. On the fifth day, animals were sacrificed and uteri were separated solely and weighed. The blood was collected, and serum was separated. The effect of the pharmacological serum on proliferation assay with human breast cancer cell line (MCF7) by MTT method. Cell-cycle analyses were carried out with propidium iodide staining by flow cytometer. The expressions of subtypes-estrogen receptor-alpha (ERalpha) were detected by flow cytometry.
RESULTRadix Rehmanniae Preparata, Radix Paeoniae Alba and Radix Angelicae Sinensis could increase the immature rat's uterus wet weight and the ratio of uterus to body weight (P < 0.05). The pharmacological serum of the four kinds of Chinese medicine stimulated proliferation of MCF7 cell respectively compared with normal control group (P < 0.01). The cell cycle was impulsed from G1 to S, DNA synthesizing was inhanced, and PI was also increased. The pharmacological serum of Radix Angelicae Sinensis and Rhizoma Chuanxiong could increase the expressions of (ERalpha) (P < 0.05).
CONCLUSIONRadix Rehmanniae Preparata, Radix Paeoniae Alba and Radix Angelicae sinensis have phytoestrogenic effects. But the data werent consistent with in vitro and in vivo assay of Rhizoma Chuanxiong.
Animals ; Cell Cycle ; drug effects ; Cell Line, Tumor ; Cell Proliferation ; drug effects ; Drugs, Chinese Herbal ; administration & dosage ; Estrogen Receptor alpha ; genetics ; metabolism ; Female ; Phytoestrogens ; administration & dosage ; Random Allocation ; Rats ; Rats, Sprague-Dawley ; Uterus ; cytology ; drug effects ; metabolism
8.A multicenter study of rituximab-based regimen as first-line treatment in patients with follicular lymphoma.
Jianqiu WU ; Yongping SONG ; Liping SU ; Mingzhi ZHANG ; Wei LI ; Yu HU ; Xiaohong ZHANG ; Yuhuan GAO ; Zuoxing NIU ; Ru FENG ; Wei WANG ; Jiewen PENG ; Xiaolin LI ; Xuenong OUYANG ; Changping WU ; Weijing ZHANG ; Yun ZENG ; Zhen XIAO ; Yingmin LIANG ; Yongzhi ZHUANG ; Jishi WANG ; Zimin SUN ; Hai BAI ; Tongjian CUI ; Jifeng FENG
Chinese Journal of Hematology 2014;35(5):456-458
9.Lacrimal sac diverticulum presenting as a lower eyelid mass with a secreting fistula.
Chengyue ZHANG ; Qian WU ; Jifeng YU ; Yanhui CUI ; Wenhong CAO ; Yunwei FAN ; Gang YU
Chinese Medical Journal 2014;127(18):3359-3360
10.Clinical features of rituximab plus chemotherapy as first-line treatment in patients with diffuse large B-cell lymphoma.
Jifeng FENG ; Jianqiu WU ; Yongping SONG ; Liping SU ; Mingzhi ZHANG ; Wei LI ; Yu HU ; Xiaohong ZHANG ; Yuhuan GAO ; Zuoxing NIU ; Ru FENG ; Wei WANG ; Jiewen PENG ; Xuenong OUYANG ; Xiaolin LI ; Changping WU ; Weijing ZHANG ; Yun ZENG ; Zhen XIAO ; Yingmin LIANG ; Yongzhi ZHUANG ; Jishi WANG ; Zimin SUN ; Hai BAI ; Tongjian CUI
Chinese Journal of Hematology 2014;35(4):309-313
OBJECTIVEA prospective, multicenter and non-interventional prospective study was conducted to evaluate the clinical features of rituximab combined with chemotherapy (R-Chemo) as first-line treatment on newly diagnosed Chinese patients with diffuse large B-cell lymphoma (DLBCL).
METHODSThis was a single arm, prospective, observational multicenter and phase IV clinical trial for 279 patients, who were newly diagnosed as CD20-positive DLBCL from 24 medical centers in China 2011 and 2012, no special exclusion criteria were used. All patients received rituximab based R-Chemo regimes, such as R-CHOP (rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisolone) and other regimes as the first-line treatment. The treatment strategies were determined by physicians and patients without detailed description for treatment course, dose, interval time and examination. Clinical response and safety of all patients were investigated in 120 days after completion of last dose of rituximab.
RESULTSOf 279 patients, 258 with stage I-IV who received at least 1 cycle of rituximab treatment and completed at least one time of tumor assessment were enrolled into intention-to-treat analysis, including 148 male and 110 female. The median age of all patients was 57.2(12.8-88.4) years. ECOG performance statuses of 0 or 1 were observed in 91.1% of patients, international prognostic index levels in the low-risk and low-middle-risk groups in 76.4% of patients, the tumor diameters smaller than 7.5 cm in 69.0% of patients. All patients received 6 median cycles of R-Chemo treatment every 24.4 days. R-CHOP treatment was shown to improve the clinical response with overall response rates of 94.2%. Common adverse events included anemia, marrow failure, leukopenia, thrombocytopenia, digestive diseases, infection and liver toxicity. All adverse events are manageable.
CONCLUSIONNon-interventional clinical trial of R-Chemo remains the standard first-line treatment for newly diagnosed patients with DLBCL in real clinical practice, which is consistent with international treatment recommendations for DLBCL patients. R-Chemo can provide the clinical evidence and benefit as the first-line standard treatment for Chinese patients with DLBCL.
Adolescent ; Adult ; Aged ; Aged, 80 and over ; Antibodies, Monoclonal, Murine-Derived ; therapeutic use ; Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Child ; Female ; Humans ; Lymphoma, Large B-Cell, Diffuse ; drug therapy ; Male ; Middle Aged ; Prospective Studies ; Rituximab ; Treatment Outcome